RecallDepth
Class II Terminated

Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 125 mg per 50 mL (2.5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-461-01), packaged in 25 Multiple Dose Vials per tray (NDC 63323-461-57), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Company
Fresenius Kabi Usa, Llc
Recall Initiated
November 22, 2022
Posted
January 25, 2023
Recall Number
D-0127-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
40,375 vials
Firm Location
Lake Zurich, IL, United States

Reason for Recall

Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Distribution

Nationwide in the USA

Lot / Code Info

Batch #: 6128061, exp 03/2024; 6128663, 6128664, exp 05/2024

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class II Drug recalls